Long-term Remission of Severe and Refractory Chronic Actinic Dermatosis with Dupilumab: A Case Report with Review of the Literature
DOI:
https://doi.org/10.2340/actadv.v104.40453Keywords:
chronic actinic dermatits, dupilumabAbstract
Abstract is missing (Short communication)
Downloads
References
Dawe RS, Ferguson J. Diagnosis and treatment of chronic actinic dermatitis. Dermatol Ther 2003; 16: 45-51.
https://doi.org/10.1046/j.1529-8019.2003.01607.x DOI: https://doi.org/10.1046/j.1529-8019.2003.01607.x
Burfield L, Rutter KJ, Thompson B, Marjanovic EJ, Neale RE, Rhodes LE. Systematic review of the prevalence and incidence of the photodermatoses with meta-analysis of the prevalence of polymorphic light eruption. J Eur Acad Dermatol Venereol 2023; 37: 511-520.
https://doi.org/10.1111/jdv.18772 DOI: https://doi.org/10.1111/jdv.18772
Dawe RS, Crombie IK, Ferguson J. The natural history of chronic actinic dermatitis. Arch Dermatol 2000; 136: 1215-1220.
https://doi.org/10.1001/archderm.136.10.1215 DOI: https://doi.org/10.1001/archderm.136.10.1215
Ko DY, Choi SH, Ha SM, Kim TH, Song KH, Hee Kim K, et al, et al. The clinical severity score of chronic actinic dermatitis correlates with in vivo photoallergic reactions and the immunologic parameters related to a shift towards Th2 immunity from the Th2/Th1 balanced status in patients with chronic actinic dermatitis. Photodermatol Photoimmunol Photomed 2016; 32: 199-206.
https://doi.org/10.1111/phpp.12244 DOI: https://doi.org/10.1111/phpp.12244
Choi KW, Lee CY, Lee YK, Kim YH, Kim KH. A Korean experience with chronic actinic dermatitis during an 18-year period: meteorological and photoimmunological aspects. Photodermatol Photoimmunol Photomed 2009; 25: 286-292
https://doi.org/10.1111/j.1600-0781.2009.00464.x DOI: https://doi.org/10.1111/j.1600-0781.2009.00464.x
Patruno C, Fabbrocini G, Longo G, Argenziano G, Ferrucci SM, Stingeni L, et al. Effectiveness and safety of long-term dupilumab treatment in elderly patients with atopic dermatitis: a multicenter real-life observational study. Am J Clin Dermatol 2021; 22: 581-586.
https://doi.org/10.1007/s40257-021-00597-5 DOI: https://doi.org/10.1007/s40257-021-00597-5
Patel N, Konda S, Lim HW. Dupilumab for the treatment of chronic actinic dermatitis. Photodermatol Photoimmunol Photomed 2020; 36: 398-400.
https://doi.org/10.1111/phpp.12566 DOI: https://doi.org/10.1111/phpp.12566
Verma L, Pratt M. A case report of therapeutically challenging chronic actinic dermatitis. SAGE Open Med Case Rep 2019; 7: 2050313X19845235.
https://doi.org/10.1177/2050313X19845235 DOI: https://doi.org/10.1177/2050313X19845235
Chen J, Yu N, Wu W, Ou S, Chen Q, Zhu H. The effectiveness and safety of dupilumab for the treatment of recalcitrant chronic actinic dermatitis: a case series. Clin Cosmet Investig Dermatol 2023; 16: 2357-2363.
https://doi.org/10.2147/CCID.S422683 DOI: https://doi.org/10.2147/CCID.S422683
Taboada Paz L, Sanchez Garcia V, Garcia Minarro AM, Ramos Rincon JM, Gil Pallares P, Vicente Basanta E, et al. Chronic actinic dermatitis and fragrance sensitization: case report with good response to dupilumab. Photodermatol Photoimmunol Photomed 2023; 39: 670-672.
https://doi.org/10.1111/phpp.12902 DOI: https://doi.org/10.1111/phpp.12902
McFeely O, Doyle C, Blasco MC, Beatty P, Murphy L, O'Mahony S, et al. Chronic actinic dermatitis successfully treated with methotrexate and dupilumab. Photodermatol Photoimmunol Photomed 2023; 39: 172-174.
https://doi.org/10.1111/phpp.12851 DOI: https://doi.org/10.1111/phpp.12851
Ali K, Wu L, Lou H, Zhong J, Qiu Y, Da J, et al. Clearance of chronic actinic dermatitis with dupilumab therapy in Chinese patients: a case series. Front Med 2022; 9: 803692.
https://doi.org/10.3389/fmed.2022.803692 DOI: https://doi.org/10.3389/fmed.2022.803692
Chen J, Li H, Zhu H. Successful treatment of chronic actinic dermatitis with dupilumab: a case report and review of the literature. Clin Cosmet Investig Dermatol 2021; 14: 1913-1917.
https://doi.org/10.2147/CCID.S342401 DOI: https://doi.org/10.2147/CCID.S342401
Chen JC, Lian CH. Chronic actinic dermatitis in an old adult significantly improved by dupilumab. Photodermatol Photoimmunol Photomed 2022; 38: 176-177.
https://doi.org/10.1111/phpp.12731 DOI: https://doi.org/10.1111/phpp.12731
Navarro-Triviño FJ, Prados-Carmona A, Aguilera J, de Gálvez MV, Ruiz-Villaverde R. Treatment of refractory solar urticaria: could dupilumab fill the current gap? JDDG J Dtsch Dermatol Ges. 2023; 21: 652-653.
https://doi.org/10.1111/ddg.15025 DOI: https://doi.org/10.1111/ddg.15025
Perz AM, Fawaz B, Pyle T, Butala N, Green JJ. Dupilumab for the treatment of actinic prurigo. Skinmed 2021; 19: 471-472.
Hamp A, Hanson J, Schwartz RA, Lambert WC, Alhatem A. Dupilumab-associated mycosis fungoides; a cross-sectional study. Arch Dermatol Res 2023; 315: 2561-2569.
https://doi.org/10.1007/s00403-023-02652-z DOI: https://doi.org/10.1007/s00403-023-02652-z
Additional Files
Published
How to Cite
License
Copyright (c) 2024 Clélia Vanhaecke, Manuelle Viguier
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
